| Nsight360:
The Next Generation
of Deep-Learning AI
| Nsight360:
The Next Generation
of Deep-Learning AI
| Nsight360:
The Next Generation
of Deep-Learning AI
| Nsight360:
The Next Generation
of Deep-Learning AI
360 Intelligent Diagnostics makes it easy, efficient, and affordable to identify the risk of diabetic retinopathy. With Nsight360, the first product in our Ophthalytics product line, comprehensive reports from retinal scans are generated in minutes. The diagnostic images come from easily accessible and readily available cameras, and retinal exams can be administered by anyone anywhere – even a home health aide in a rural patient’s home.
| Connecting With Patients Everywhere
| Connecting With Patients Everywhere
Hospitals & Health Systems
Federally Qualified Health Centers
Health Plans
Laboratories & Pharmacies
Health Risk Assessments
| We See Things
Others Miss
| We See Things Others Miss
Nsight360 combines the power of AI with the expertise of ophthalmologists to provide rapid and accurate diagnoses. Nsight360 uses advanced AI algorithms to assist ophthalmologists in interpreting retinal images, enabling rapid and precise detection of various ophthalmic conditions. With its comprehensive reports, Nsight360 offers transparent insights into the diagnostic process, enhancing trust and confidence in the results, and enabling early detection and proactive management of diabetic retinopathy.
| A Complete Solution
Enhanced emphasis on preventive care and early detection of diseases
Adherence to quality compliance standards
Maximize HEDIS outcomes
Minimal disruption to patient flow
| What Makes Nsight360 Unique?
| What Makes Nsight360 Unique?
AI-Powered Precision
Our deep-learning AI technology ensures the fastest and most accurate assessments for diabetic retinopathy and are based on existing clinical practice guidelines.
Camera Agnostic
Nsight360 works seamlessly with any camera, both stationary and portable, offering point-of-care evaluations from 30-degree to 200-degree fields of view.
Portable & Easy to Deploy
Because our technology integrates with hand-held cameras, assessments can be conducted anywhere by anyone, even a home health aide in a rural patient’s home.
| Fastest and Most Accurate Assessments
| Fastest and Most Accurate Assessments
Our AI algorithms not only deliver accurate and reliable results but also prioritize explanability, ensuring transparency and trust in the diagnostic process. By seamlessly integrating into existing workflows, Nsight360 enhances efficiency by up to three times, enabling healthcare professionals to streamline their operations and deliver faster, more effective care to patients. Nsight360 revolutionizes the landscape of ophthalmic diagnostics, setting a new standard for quality, versatility, and efficiency in the industry.
| Why Providers Choose to Work With Us
| Why Providers Choose to Work With Us
Simple and Fast
NSight360’s AI assistive retinal screening solution makes it simple and fast for primary care providers to incorporate diabetic eye exams into their healthcare offerings.
Flexible Pay-As-You-Go Model
No subscription fees or long-term contracts – simply pay for the exams you perform. Providers can increase diabetic retinopathy exam compliance by up to 90% within a year, all while securing a strong return on investment.
Affordable and Compatible with All Retinal Cameras
Our technology is designed to be fully compatible with any fundus camera, ensuring seamless integration regardless of the retinal camera system.
Comprehensive Diagnostic Services
Our nationwide network of board-certified ophthalmologists, licensed in all 50 states, provides professional diagnostic reading and interpretation of AI-labeled retinal images.
Patient Education Resources
We supply communication tools using Gen AI models to help raise patient awareness about diabetic retinopathy and the importance of regular eye exams in preventing vision impairment or blindness.
Training and Ongoing Support
We ensure your staff is fully trained on our Assistive AI platform, camera usage, and clinical protocols. Additionally, we offer continuous technical support to guarantee the success of your diabetic retinopathy screening program.
| Your Ophthalmologists
or Ours
| Your Ophthalmologists or Ours
Nsight360 delivers results within seconds, allowing reading ophthalmologists to rapidly confirm and sign off on the diagnosis. Use your own ophthalmologists to read results or, to accelerate the time it takes to deliver a final report complete with billing codes, Ophthalytics’ team of expert, reading ophthalmologists are available for a small per-read fee.
| What People are Saying
Ophthalytics has completely transformed the way I screen for ophthalmic conditions. With its advanced AI technology, it offers accurate and efficient detection of diabetic retinopathy, even in its early stages. The system’s speed and accuracy are unparalleled, making it the fastest and most accurate resource for DR assessment. The user-friendly interface allows for quick and efficient evaluations of patient data, enhancing the overall screening process. Ophthalytics has truly been a game-changer in improving early detection and enabling timely interventions to prevent vision loss.
-Emily Thompson, M.D.
At our reading center, implementing Ophthalytics has revolutionized our screening capabilities. Its camera-agnostic nature allows us to seamlessly work with any camera, ranging from 30-degree to 200-degree field of view. This flexibility has greatly enhanced our workflow, enabling efficient assessments of patients. Ophthalytics stands out for its early detection capabilities, enabling us to detect diabetic retinopathy even in its mild stages. With the system’s quick and accurate results, we can serve more patients effectively, saving both time and resources. Ophthalytics has proven to be an invaluable asset in our fight against diabetic retinopathy
– John Davis, Reading Center Manager
Ophthalytics has become an indispensable tool in my practice as a primary care physician. Its ability to detect diabetic retinopathy at early stages is truly remarkable. With Ophthalytics, I can quickly and accurately assess my patients, allowing for timely interventions to prevent vision loss. The user-friendly interface makes it easy to evaluate patient data, facilitating efficient screenings. Ophthalytics has not only saved costs on infrastructure upgrades but also allowed me to serve a larger number of patients effectively. It has undoubtedly improved the quality of care I provide to my patients
– Sarah Patel, M.D.
Implementing Ophthalytics in our hospital has been a game-changer for us. The early detection capabilities for diabetic retinopathy are truly remarkable, allowing us to provide better care to our patients. The user-friendly interface and efficient evaluations of patient data have improved our workflow and saved valuable time for our healthcare professionals. With Ophthalytics, we have experienced significant cost savings on infrastructure upgrades while serving a larger number of patients effectively. Ophthalytics has proven to be a valuable asset in our mission to deliver high-quality eye care services
– James Thompson, Eye Hospital Administrator
Ophthalytics has transformed the way I diagnose and manage ophthalmic conditions in my optometry practice. Its advanced AI technology provides accurate and efficient detection of diabetic retinopathy, allowing for early intervention and preventing vision loss. The camera-agnostic feature is fantastic, as it works seamlessly with any camera, giving me flexibility in using my preferred equipment. The speed and accuracy of Ophthalytics make it an invaluable resource, saving me time and improving patient outcomes. I highly recommend Ophthalytics to fellow optometrists
– Jessica Ramirez, M.D. Optometrist
Being diagnosed with diabetic retinopathy was a worrying time for me, but Ophthalytics has made a significant difference in managing my condition. The early detection capabilities have allowed for timely interventions, preserving my vision. The process is quick and straightforward, and the user-friendly interface ensures that I can easily understand my assessment results. I am grateful for Ophthalytics and the peace of mind it provides. It has truly been a lifesaver, and I highly recommend it to anyone dealing with diabetic retinopathy.
– Emily Roberts, Patient
| What People
are Saying
Ophthalytics has completely transformed the way I screen for ophthalmic conditions. With its advanced AI technology, it offers accurate and efficient detection of diabetic retinopathy, even in its early stages. The system’s speed and accuracy are unparalleled, making it the fastest and most accurate resource for DR assessment. The user-friendly interface allows for quick and efficient evaluations of patient data, enhancing the overall screening process. Ophthalytics has truly been a game-changer in improving early detection and enabling timely interventions to prevent vision loss.
-Emily Thompson, M.D.
At our reading center, implementing Ophthalytics has revolutionized our screening capabilities. Its camera-agnostic nature allows us to seamlessly work with any camera, ranging from 30-degree to 200-degree field of view. This flexibility has greatly enhanced our workflow, enabling efficient assessments of patients. Ophthalytics stands out for its early detection capabilities, enabling us to detect diabetic retinopathy even in its mild stages. With the system’s quick and accurate results, we can serve more patients effectively, saving both time and resources. Ophthalytics has proven to be an invaluable asset in our fight against diabetic retinopathy
– John Davis, Reading Center Manager
Ophthalytics has become an indispensable tool in my practice as a primary care physician. Its ability to detect diabetic retinopathy at early stages is truly remarkable. With Ophthalytics, I can quickly and accurately assess my patients, allowing for timely interventions to prevent vision loss. The user-friendly interface makes it easy to evaluate patient data, facilitating efficient screenings. Ophthalytics has not only saved costs on infrastructure upgrades but also allowed me to serve a larger number of patients effectively. It has undoubtedly improved the quality of care I provide to my patients
– Sarah Patel, M.D.
Implementing Ophthalytics in our hospital has been a game-changer for us. The early detection capabilities for diabetic retinopathy are truly remarkable, allowing us to provide better care to our patients. The user-friendly interface and efficient evaluations of patient data have improved our workflow and saved valuable time for our healthcare professionals. With Ophthalytics, we have experienced significant cost savings on infrastructure upgrades while serving a larger number of patients effectively. Ophthalytics has proven to be a valuable asset in our mission to deliver high-quality eye care services
– James Thompson, Eye Hospital Administrator
Ophthalytics has transformed the way I diagnose and manage ophthalmic conditions in my optometry practice. Its advanced AI technology provides accurate and efficient detection of diabetic retinopathy, allowing for early intervention and preventing vision loss. The camera-agnostic feature is fantastic, as it works seamlessly with any camera, giving me flexibility in using my preferred equipment. The speed and accuracy of Ophthalytics make it an invaluable resource, saving me time and improving patient outcomes. I highly recommend Ophthalytics to fellow optometrists
– Jessica Ramirez, M.D. Optometrist
Being diagnosed with diabetic retinopathy was a worrying time for me, but Ophthalytics has made a significant difference in managing my condition. The early detection capabilities have allowed for timely interventions, preserving my vision. The process is quick and straightforward, and the user-friendly interface ensures that I can easily understand my assessment results. I am grateful for Ophthalytics and the peace of mind it provides. It has truly been a lifesaver, and I highly recommend it to anyone dealing with diabetic retinopathy.
– Emily Roberts, Patient
